Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1229

    1.

    Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.

    Iwama D, Otani A, Sasahara M, Yodoi Y, Gotoh N, Tamura H, Tsujikawa A, Yoshimura N.

    Br J Ophthalmol. 2008 Oct;92(10):1352-6. Epub 2008 Jul 28.PMID: 18662914 [PubMed - indexed for MEDLINE]Related articles

    2.

    Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

    Chaudhary V, Mao A, Hooper PL, Sheidow TG.

    Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles

    3.

    Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2003 Aug;110(8):1517-25.PMID: 12917166 [PubMed - indexed for MEDLINE]Related articles

    4.

    Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Ophthalmology. 2006 Dec;113(12):2243-50. Epub 2006 Sep 25.PMID: 16996600 [PubMed - indexed for MEDLINE]Related articles

    5.

    Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Am J Ophthalmol. 2006 Apr;141(4):638-45.PMID: 16564797 [PubMed - indexed for MEDLINE]Related articles

    6.

    Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Ophthalmology. 2006 Jan;113(1):14-22. Epub 2005 Dec 19.PMID: 16360209 [PubMed - indexed for MEDLINE]Related articles

    7.

    Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2005 Feb;112(2):301-4.PMID: 15691567 [PubMed - indexed for MEDLINE]Related articles

    8.

    Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.

    Nicolò M, Ghiglione D, Lai S, Nasciuti F, Cicinelli S, Calabria G.

    Retina. 2006 Jan;26(1):58-64.PMID: 16395140 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.

    Iriyama A, Obata R, Inoue Y, Takahashi H, Tamaki Y, Yanagi Y.

    Graefes Arch Clin Exp Ophthalmol. 2008 Mar;246(3):339-44. Epub 2007 Sep 6.PMID: 17805556 [PubMed - indexed for MEDLINE]Related articles

    10.

    Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Graefes Arch Clin Exp Ophthalmol. 2008 Feb;246(2):245-54. Epub 2007 Aug 3.PMID: 17674020 [PubMed - indexed for MEDLINE]Related articles

    11.

    Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.

    Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.

    Am J Ophthalmol. 2006 Jul;142(1):10-16.PMID: 16815246 [PubMed - indexed for MEDLINE]Related articles

    12.

    Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.

    Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA.

    Retina. 2006 Jul-Aug;26(6):602-12.PMID: 16829800 [PubMed - indexed for MEDLINE]Related articles

    13.

    Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.

    Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E, Weinberger D.

    Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec;37(6):455-61.PMID: 17152538 [PubMed - indexed for MEDLINE]Related articles

    14.

    Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.

    Schadlu R, Kymes SM, Apte RS.

    Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1667-72. Epub 2007 Jun 22.PMID: 17583819 [PubMed - indexed for MEDLINE]Related articles

    16.

    Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.

    Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.

    Arch Ophthalmol. 1999 Sep;117(9):1177-87. Erratum in: Arch Ophthalmol 2000 Apr;118(4):488. PMID: 10496389 [PubMed - indexed for MEDLINE]Related articles

    17.

    Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy.

    Piermarocchi S, Sartore M, Lo Giudice G, Maritan V, Midena E, Segato T.

    Arch Ophthalmol. 2008 Oct;126(10):1367-74.PMID: 18852414 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.

    Arevalo JF, Sanchez JG, Garcia RA, Wu L, Berrocal MH, Rodriguez FJ, Rodríguez A, Novoa LA, Garcia-Amaris R.

    Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1673-80. Epub 2007 Jul 10.PMID: 17619895 [PubMed - indexed for MEDLINE]Related articles

    19.

    Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.

    Neovascular Age-Related Macular Degeneration, Periocular Corticosteroids, and Photodynamic Therapy (NAPP) Trial Research Group, Gilson MM, Bressler NM, Jabs DA, Solomon SD, Thorne JE, Wilson DJ.

    Ophthalmology. 2007 Sep;114(9):1713-21.PMID: 17822977 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

    Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

    Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data